Biological agents – hope and caution

Jaroslava Halper

Abstract


Having actively participated in the field of growth factor research since the early days of growth factor discovery 1,2 I can comment with great delight and amazement on the progress made since those early days. Not only our basic knowledge has expanded exponentially, but growth factors, their receptors and complicated signaling systems became legitimate targets of sometimes quite effective chemotherapy. This issue brings a variety of interesting papers dealing with various aspects of tumor therapy, ranging from traditional combination protocols for management of cholangiocarcinoma 3 to novel hypofractionated stereotactic radiation therapy of pituitary adenomas 4 to several papers which critically appraise the state of the art of cancer treatment with several recently introduced biological agents. 5-8

Full Text: PDF DOI: 10.5430/jst.v1n3p155

Comments on this article

View all comments


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Journal of Solid Tumors

ISSN 1925-4067(Print)   ISSN 1925-4075(Online)

Copyright © Sciedu Press


To make sure that you can receive messages from us, please add the 'Sciedu.ca' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.